[{"arm_notes": "", "treatment_id": null, "treatment_name": "After obtaining consents; the subjects are randomly assigned to the following three groups at the time of allocation / registration.A group : 800mg/day Clarithromycin administration groupB group : 400mg/day Clarithromycin administration groupC group : Control group (No medication or standard tratment of COVID-19)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "400mg/day ", "treatment_id": 292, "treatment_name": "Clarithromycin", "treatment_type": "Antibiotics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "800mg/day ", "treatment_id": 292, "treatment_name": "Clarithromycin", "treatment_type": "Antibiotics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]